135 related articles for article (PubMed ID: 31300130)
1. A simplified roller bottle platform for the production of a new generation VLPs rabies vaccine for veterinary applications.
Fontana D; Marsili F; Garay E; Battagliotti J; Etcheverrigaray M; Kratje R; Prieto C
Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():70-75. PubMed ID: 31300130
[TBL] [Abstract][Full Text] [Related]
2. Immunogenic virus-like particles continuously expressed in mammalian cells as a veterinary rabies vaccine candidate.
Fontana D; Kratje R; Etcheverrigaray M; Prieto C
Vaccine; 2015 Aug; 33(35):4238-46. PubMed ID: 25869890
[TBL] [Abstract][Full Text] [Related]
3. Rabies virus-like particles expressed in HEK293 cells.
Fontana D; Kratje R; Etcheverrigaray M; Prieto C
Vaccine; 2014 May; 32(24):2799-804. PubMed ID: 24631077
[TBL] [Abstract][Full Text] [Related]
4. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
[TBL] [Abstract][Full Text] [Related]
5. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.
Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X
Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031
[TBL] [Abstract][Full Text] [Related]
6. Production of Rabies VLPs in Insect Cells by Two Monocistronic Baculoviruses Approach.
Bernardino TC; Astray RM; Pereira CA; Boldorini VL; Antoniazzi MM; Jared SGS; Núñez EGF; Jorge SAC
Mol Biotechnol; 2021 Nov; 63(11):1068-1080. PubMed ID: 34228257
[TBL] [Abstract][Full Text] [Related]
7. No adverse effects of simultaneous vaccination with the immunocontraceptive GonaCon and a commercial rabies vaccine on rabies virus neutralizing antibody production in dogs.
Bender SC; Bergman DL; Wenning KM; Miller LA; Slate D; Jackson FR; Rupprecht CE
Vaccine; 2009 Nov; 27(51):7210-3. PubMed ID: 19925955
[TBL] [Abstract][Full Text] [Related]
8. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z
Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816
[TBL] [Abstract][Full Text] [Related]
9. A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice.
Koraka P; Bosch BJ; Cox M; Chubet R; Amerongen Gv; Lövgren-Bengtsson K; Martina BE; Roose J; Rottier PJ; Osterhaus AD
Vaccine; 2014 Aug; 32(36):4644-50. PubMed ID: 24962755
[TBL] [Abstract][Full Text] [Related]
10. [Preparation and application of a colloidal gold strip to detect the rabies antibody].
Wang T; Zhang T; Yang S; Wang H; Gao Y; Sun W; Jin X; Zhao P; Feng N; Huang G; Zou X; Xia X
Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):799-804. PubMed ID: 21845847
[TBL] [Abstract][Full Text] [Related]
11. Protective antibody response of Balb/c mice to Bali rabies virus isolate propagated in BHK-21 cells.
Astawa INM; Agustini NLP; Masa Tenaya IW; Aryawiguna IPGW
J Vet Med Sci; 2018 Nov; 80(10):1596-1603. PubMed ID: 30210066
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of G2 Citric Acid-Based Dendrimer as an Adjuvant in Veterinary Rabies Vaccine.
Asgary V; Shoari A; Afshar Moayad M; Shafiee Ardestani M; Bigdeli R; Ghazizadeh L; Khosravy MS; Panahnejad E; Janani A; Bashar R; Abedi M; Ahangari Cohan R
Viral Immunol; 2018; 31(1):47-54. PubMed ID: 29328884
[TBL] [Abstract][Full Text] [Related]
13. Canine rabies DNA vaccination: a single-dose intradermal injection into ear pinnae elicits elevated and persistent levels of neutralizing antibody.
Lodmell DL; Parnell MJ; Weyhrich JT; Ewalt LC
Vaccine; 2003 Sep; 21(25-26):3998-4002. PubMed ID: 12922136
[TBL] [Abstract][Full Text] [Related]
14. Thermotolerance of an inactivated rabies vaccine for dogs.
Lankester FJ; Wouters PAWM; Czupryna A; Palmer GH; Mzimbiri I; Cleaveland S; Francis MJ; Sutton DJ; Sonnemans DGP
Vaccine; 2016 Nov; 34(46):5504-5511. PubMed ID: 27729174
[TBL] [Abstract][Full Text] [Related]
15. [Studies on the manufacture and immunogenicity of purified rabies vaccines on humans Vero cell].
Yu W; Liu Z; Qian H; Lu H; Wang H; Li F; Dou Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Feb; 22(1):17-9. PubMed ID: 11860837
[TBL] [Abstract][Full Text] [Related]
16. Rabies VLPs adjuvanted with saponin-based liposomes induce enhanced immunogenicity mediated by neutralizing antibodies in cattle, dogs and cats.
Fontana D; Marsili F; Etcheverrigaray M; Kratje R; Prieto C
J Virol Methods; 2020 Dec; 286():113966. PubMed ID: 32905818
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of ERA strain of rabies virus propagated in a BHK-21 cell line.
Lawson KF; Hertler R; Charlton KM; Campbell JB; Rhodes AJ
Can J Vet Res; 1989 Oct; 53(4):438-44. PubMed ID: 2686831
[TBL] [Abstract][Full Text] [Related]
18. G-protein based ELISA as a potency test for rabies vaccines.
Chabaud-Riou M; Moreno N; Guinchard F; Nicolai MC; Niogret-Siohan E; Sève N; Manin C; Guinet-Morlot F; Riou P
Biologicals; 2017 Mar; 46():124-129. PubMed ID: 28214171
[TBL] [Abstract][Full Text] [Related]
19. A comparative approach between heterologous prime-boost vaccination strategy and DNA vaccinations for rabies.
Borhani K; Ajorloo M; Bamdad T; Mozhgani SH; Ghaderi M; Gholami AR
Arch Iran Med; 2015 Apr; 18(4):223-7. PubMed ID: 25841942
[TBL] [Abstract][Full Text] [Related]
20. A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use.
Krämer B; Kamphuis E; Hanschmann KM; Milne C; Daas A; Duchow K
Biologicals; 2013 Nov; 41(6):400-6. PubMed ID: 24144483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
